In addition, SIRT6-induced macrophage autophagy in oxidized LDL-C (ox-LDL-C)-treated ECs increases cholesterol efflux and reduces macrophage infiltration, endothelial inflammation and foam cell formation, thereby attenuating the pathological development of atherosclerosis [175, 176]. Here, SIRT6 is linked to atherosclerosis.